Hypothesis

Selective vulnerability of entorhinal cortex (EC) layer II grid and stellate cells to tau pathology arises from a cell‑type‑specific deficit in mitochondrial calcium buffering and ATP production, which is exacerbated by their high‑frequency firing demands during path integration. This energetic failure triggers tau misfolding, impairs axonal transport, and promotes activity‑dependent release of tau oligomers that spread monosynaptically to connected hippocampal targets via Wfs1‑expressing projections.

Mechanistic Rationale

1. High metabolic load of grid cells – Grid cells fire at theta‑modulated rates during locomotion, requiring sustained Na⁺/K⁺‑ATPase activity and robust calcium handling to maintain precise spatial firing fields (3). Layer II excitatory neurons therefore rely heavily on mitochondrial oxidative phosphorylation.
2. Mitochondrial calcium handling as a bottleneck – Recent work shows that the CRL5‑SOCS4 complex tags tau for degradation, but its efficacy depends on adequate ATP‑dependent proteasome activity (6). Grid cells exhibit lower expression of mitochondrial calcium uniporter (MCU) regulators compared with inhibitory interneurons, making them prone to calcium overload when firing rates rise.
3. Calcium‑induced tau pathology – Elevated intramitochondrial calcium stimulates kinases (e.g., GSK‑3β, CDK5) that hyperphosphorylate tau, promoting its aggregation (2). Energy depletion further impairs the ubiquitin‑proteasome system, creating a vicious cycle.
4. Activity‑dependent tau release – Stressed mitochondria release reactive oxygen species that damage axonal microtubules, causing tau to detach and be packaged into vesicles. Because grid cells fire bursts during navigation, they release more tau per unit time than low‑firing interneurons, providing a substrate for trans‑synaptic spread along their primary output pathway (EC layer II → Wfs1⁺ → hippocampal CA1) (5).
5. Excitatory‑inhibitory imbalance as a downstream effect – Loss of grid‑cell firing reduces excitatory drive onto hippocampal interneurons, while spared local inhibition persists, amplifying network hyperexcitability and accelerating tau propagation to connected cortical areas (4).

Testable Predictions

• Prediction 1: In tau‑ transgenic mice (e.g., P301S), EC layer II grid cells will show significantly lower basal ATP levels, higher mitochondrial calcium flux, and increased ROS compared with co‑localized parvalbumin‑positive interneurons.
• Prediction 2: Pharmacological boost of mitochondrial NAD⁺ (e.g., with nicotinamide riboside) or expression of a calcium‑buffering mitochondrial targeting sequence (e.g., mt‑GCaMP6f‑camkII) will rescue ATP levels, reduce tau phosphorylation, and preserve grid‑cell firing metrics.
• Prediction 3: Selective chemogenetic inhibition of grid‑cell activity during early tau expression will decrease activity‑dependent tau release into the hippocampal CA1 region and slow the spread of pathology, despite persistent intracellular tau.
• Prediction 4: Optogenetic stimulation of surviving grid‑cell axons in tau‑affected mice will exacerbate tau propagation to CA1, whereas inhibition of those axons will attenuate spread, confirming the activity‑dependent release mechanism.

Experimental Approach

1. In vivo metabolomics & imaging – Use FRET‑based ATP (ATeam) and calcium (GCaMP6f) sensors expressed selectively in EC layer II excitatory neurons (via Wfs1‑Cre) versus interneurons (via PV‑Cre) in aged tau mice; compare baseline and during virtual‑navigation tasks.
2. Mitochondrial rescue – Administer nicotinamide riboside or overexpress mt‑SOD2 via AAV‑Wfs1; assess ATP, ROS, tau phosphorylation (AT8, PHF1), and grid‑cell stability (grid score, spatial information) via in‑vivo electrophysiology.
3. Activity‑dependent tau release – Express a pH‑sensitive tau‑synaptophysin reporter (Synaptophysin‑pHluorin‑tau) in grid cells; measure extracellular tau release in hippocampal slices during theta‑burst stimulation with/without neuronal silencing (hM4Di DREADDs).
4. Spread blockade – Combine grid‑cell chemogenetic inhibition (hM4Di) with anti‑tau antibodies to test whether reducing neuronal activity lowers the seeding efficiency of transmitted tau.
5. Outcome measures – Longitudinal MRI for volumetric loss, behavioral testing (Morris water maze, radial arm maze) for navigation deficits, and histology for tau burden across EC‑hippocampal‑cortical circuits.

Implications

If validated, this hypothesis re‑frames the EC as a metabolic hotspot where the very computations that make grid cells indispensable for spatial navigation also render them energetic Achilles’ heels. It suggests that early interventions targeting mitochondrial health—rather than solely anti‑tau antibodies—could preserve grid‑cell function, delay excitatory‑inhibitory collapse, and slow the stereotyped spread of tauopathy that defines Alzheimer’s progression.